|
Insider Trading: Gilead Sciences Inc
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Gilead Sciences Inc in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of Gilead Sciences Inc since year 2005. Table 2 shows the detailed insider transactions of Gilead Sciences Inc since 2005.
The reporting company's ticker symbol is GILD.
The reporting company's CIK number is 882095.
The total value of stock buying since 2005 is $428,467.
The total value of stock sales is $434,723,909.
The total value of stock exercises is $66,897,441.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at Gilead Sciences Inc (GILD) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Figure 2. Average prices of insider buys, sales, and option exercises at Gilead Sciences Inc (GILD) in the past 24 months. See table 2 for insider transaction details.
12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 08 09 10 11 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for Gilead Sciences Inc (GILD).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-11 | 0 | 0 | 269,950 | 12,134,778 | 169,950 | 2,393,428 |
| 2008-10 | 0 | 0 | 165,450 | 7,533,138 | 283,586 | 2,426,534 |
| 2008-09 | 0 | 0 | 80,450 | 4,089,022 | 80,450 | 601,277 |
| 2008-08 | 0 | 0 | 90,450 | 5,118,254 | 90,450 | 363,544 |
| 2008-07 | 0 | 0 | 403,950 | 20,994,709 | 541,950 | 4,482,009 |
| 2008-06 | 0 | 0 | 150,450 | 8,170,693 | 150,450 | 867,547 |
| 2008-05 | 0 | 0 | 336,266 | 18,058,776 | 142,442 | 1,554,411 |
| 2008-04 | 0 | 0 | 553,950 | 28,854,347 | 397,950 | 3,805,241 |
| 2008-03 | 0 | 0 | 201,450 | 9,657,344 | 208,450 | 1,372,573 |
| 2008-02 | 0 | 0 | 232,670 | 10,336,824 | 237,950 | 2,730,935 |
| 2008-01 | 0 | 0 | 365,600 | 16,738,572 | 339,500 | 2,146,779 |
| 2007-12 | 0 | 0 | 130,000 | 6,016,630 | 190,892 | 1,050,212 |
| 2007-11 | 0 | 0 | 192,700 | 8,499,154 | 163,000 | 701,162 |
| 2007-10 | 10,000 | 418,400 | 351,500 | 15,677,276 | 310,000 | 2,495,419 |
| 2007-09 | 0 | 0 | 143,000 | 5,350,319 | 367,000 | 1,071,263 |
| 2007-08 | 0 | 0 | 90,125 | 3,409,900 | 80,000 | 342,660 |
| 2007-07 | 0 | 0 | 122,500 | 4,846,510 | 122,500 | 714,511 |
| 2007-06 | 0 | 0 | 95,850 | 7,786,021 | 69,750 | 472,457 |
| 2007-05 | 0 | 0 | 465,918 | 38,761,957 | 485,250 | 10,948,797 |
| 2007-04 | 121 | 10,067 | 239,999 | 19,688,220 | 178,944 | 1,778,482 |
| 2007-03 | 0 | 0 | 147,205 | 10,563,220 | 116,550 | 888,943 |
| 2007-02 | 0 | 0 | 376,570 | 26,966,722 | 339,650 | 4,623,798 |
| 2007-01 | 0 | 0 | 45,050 | 2,934,548 | 45,050 | 179,445 |
| 2006-12 | 0 | 0 | 39,750 | 2,604,341 | 47,810 | 223,020 |
| 2006-11 | 0 | 0 | 173,783 | 11,873,364 | 172,878 | 1,646,038 |
| 2006-10 | 0 | 0 | 420,750 | 28,630,912 | 419,750 | 4,033,972 |
| 2006-09 | 0 | 0 | 47,450 | 2,998,456 | 42,612 | 146,282 |
| 2006-08 | 0 | 0 | 511,693 | 31,507,821 | 517,896 | 4,745,727 |
| 2006-07 | 0 | 0 | 73,500 | 4,484,116 | 66,500 | 605,770 |
| 2006-06 | 0 | 0 | 0 | 0 | 2,788 | 31,884 |
| 2006-05 | 0 | 0 | 256,500 | 14,511,682 | 326,404 | 2,429,252 |
| 2006-04 | 0 | 0 | 0 | 0 | 10,000 | 32,657 |
| 2006-03 | 0 | 0 | 36,500 | 2,177,267 | 61,394 | 329,495 |
| 2006-02 | 0 | 0 | 526,960 | 31,818,731 | 469,518 | 4,591,182 |
| 2005-12 | 0 | 0 | 0 | 0 | 9,300 | 70,735 |
| 2005-11 | 0 | 0 | 26,000 | 1,407,360 | 0 | 0 |
| 2005-08 | 0 | 0 | 10,000 | 421,100 | 0 | 0 |
| 2005-05 | 0 | 0 | 256,318 | 10,101,825 | 0 | 0 |
Go to page: 1
2
Table 2. Detailed insider stock purchases, sales, and option exercises
for Gilead Sciences Inc (GILD)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-11-18 | Davignon Etienne | Sale | 60,000 | 45.14 | 2,708,580 |
| 2008-11-12 | Berg Paul | Sale | 13,450 | 43.62 | 586,689 |
| 2008-11-12 | Berg Paul | Option Exercise | 13,450 | 3.39 | 45,552 |
| 2008-11-07 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 190,000 | 44.93 | 8,535,959 |
| 2008-11-07 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Exercise | 150,000 | 15.26 | 2,289,750 |
| 2008-11-03 | Alton Gregg H (SVP, General Counsel) | Sale | 6,500 | 46.70 | 303,550 |
| 2008-11-03 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 6,500 | 8.94 | 58,126 |
| 2008-10-30 | Berg Paul | Sale | 12,000 | 46.14 | 553,680 |
| 2008-10-30 | Berg Paul | Option Exercise | 24,000 | 14.25 | 342,000 |
| 2008-10-24 | Davignon Etienne | Option Exercise | 80,000 | 2.57 | 205,320 |
| 2008-10-21 | Denny James M | Sale | 96,000 | 46.39 | 4,453,785 |
| 2008-10-21 | Denny James M | Option Exercise | 120,000 | 8.36 | 1,002,900 |
| 2008-10-15 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 2,136 | 17.50 | 37,374 |
| 2008-10-08 | Berg Paul | Sale | 13,450 | 39.57 | 532,216 |
| 2008-10-08 | Berg Paul | Option Exercise | 13,450 | 3.39 | 45,552 |
| 2008-10-06 | Young Kevin (EVP, Commercial Operations) | Sale | 30,000 | 45.33 | 1,359,961 |
| 2008-10-06 | Young Kevin (EVP, Commercial Operations) | Option Exercise | 30,000 | 16.84 | 505,275 |
| 2008-10-03 | Alton Gregg H (SVP, General Counsel) | Sale | 500 | 47.00 | 23,500 |
| 2008-10-03 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 500 | 8.94 | 4,471 |
| 2008-10-01 | Alton Gregg H (SVP, General Counsel) | Sale | 6,000 | 45.31 | 271,860 |
| 2008-10-01 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 6,000 | 8.94 | 53,655 |
| 2008-10-01 | Metza Kristen (SVP, Human Resources) | Sale | 7,500 | 45.08 | 338,136 |
| 2008-10-01 | Metza Kristen (SVP, Human Resources) | Option Exercise | 7,500 | 30.66 | 229,987 |
| 2008-09-10 | Berg Paul | Sale | 13,450 | 46.88 | 630,536 |
| 2008-09-10 | Berg Paul | Option Exercise | 13,450 | 3.39 | 45,552 |
| 2008-09-02 | Alton Gregg H (SVP, General Counsel) | Sale | 7,000 | 51.01 | 357,086 |
| 2008-09-02 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 7,000 | 8.94 | 62,597 |
| 2008-09-02 | Milligan John F (President and COO) | Sale | 60,000 | 51.69 | 3,101,400 |
| 2008-09-02 | Milligan John F (President and COO) | Option Exercise | 60,000 | 8.22 | 493,128 |
| 2008-08-13 | Berg Paul | Sale | 13,450 | 57.02 | 766,919 |
| 2008-08-13 | Berg Paul | Option Exercise | 13,450 | 3.39 | 45,552 |
| 2008-08-12 | Martin John C (Chairman and CEO) | Sale | 70,000 | 56.82 | 3,977,729 |
| 2008-08-12 | Martin John C (Chairman and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2008-08-01 | Alton Gregg H (SVP, General Counsel) | Sale | 7,000 | 53.37 | 373,606 |
| 2008-08-01 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 7,000 | 8.94 | 62,597 |
| 2008-07-30 | Moore Gordon Earle | Option Exercise | 144,000 | 2.57 | 369,576 |
| 2008-07-24 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 180,000 | 52.11 | 9,379,386 |
| 2008-07-24 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Exercise | 150,000 | 15.26 | 2,289,750 |
| 2008-07-22 | Denny James M | Sale | 96,000 | 50.92 | 4,888,046 |
| 2008-07-22 | Denny James M | Option Exercise | 120,000 | 5.96 | 714,858 |
| 2008-07-09 | Berg Paul | Sale | 13,450 | 53.32 | 717,154 |
| 2008-07-09 | Berg Paul | Option Exercise | 13,450 | 3.39 | 45,552 |
| 2008-07-08 | Young Kevin (EVP, Commercial Operations) | Sale | 30,000 | 51.82 | 1,554,562 |
| 2008-07-08 | Young Kevin (EVP, Commercial Operations) | Option Exercise | 30,000 | 16.84 | 505,275 |
| 2008-07-08 | Martin John C (Chairman and CEO) | Sale | 70,000 | 52.90 | 3,703,350 |
| 2008-07-08 | Martin John C (Chairman and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2008-07-01 | Alton Gregg H (SVP, General Counsel) | Sale | 7,000 | 51.77 | 362,409 |
| 2008-07-01 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 7,000 | 8.94 | 62,597 |
| 2008-07-01 | Metza Kristen (SVP, Human Resources) | Sale | 7,500 | 51.97 | 389,802 |
| 2008-07-01 | Metza Kristen (SVP, Human Resources) | Option Exercise | 7,500 | 31.87 | 239,006 |
| 2008-06-11 | Berg Paul | Sale | 13,450 | 53.84 | 724,148 |
| 2008-06-11 | Berg Paul | Option Exercise | 13,450 | 3.39 | 45,552 |
| 2008-06-10 | Martin John C (Chairman and CEO) | Sale | 70,000 | 53.98 | 3,778,740 |
| 2008-06-10 | Martin John C (Chairman and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2008-06-02 | Alton Gregg H (SVP, General Counsel) | Sale | 7,000 | 54.52 | 381,605 |
| 2008-06-02 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 7,000 | 8.94 | 62,597 |
| 2008-06-02 | Milligan John F (President and COO) | Sale | 60,000 | 54.77 | 3,286,200 |
| 2008-06-02 | Milligan John F (President and COO) | Option Exercise | 60,000 | 8.40 | 504,003 |
| 2008-05-30 | Metza Kristen (SVP, Human Resources) | Sale | 15,387 | 55.50 | 853,978 |
| 2008-05-30 | Metza Kristen (SVP, Human Resources) | Option Exercise | 15,387 | 29.60 | 455,493 |
| 2008-05-29 | Metza Kristen (SVP, Human Resources) | Sale | 24,613 | 55.25 | 1,359,868 |
| 2008-05-29 | Metza Kristen (SVP, Human Resources) | Option Exercise | 24,613 | 28.26 | 695,563 |
| 2008-05-28 | Martin John C (Chairman and CEO) | Option Exercise | 11,992 | 3.70 | 44,408 |
| 2008-05-22 | Wilson Gayle E | Sale | 100,000 | 53.33 | 5,340,523 |
| 2008-05-14 | Berg Paul | Sale | 13,450 | 53.60 | 720,081 |
| 2008-05-14 | Berg Paul | Option Exercise | 13,450 | 3.04 | 40,955 |
| 2008-05-13 | Martin John C (Chairman and CEO) | Sale | 70,000 | 53.77 | 3,763,750 |
| 2008-05-13 | Martin John C (Chairman and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2008-05-01 | Alton Gregg H (SVP, General Counsel) | Sale | 7,000 | 52.38 | 366,670 |
| 2008-05-01 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 7,000 | 8.94 | 62,597 |
| 2008-04-30 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 180,000 | 52.08 | 9,376,429 |
| 2008-04-30 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Exercise | 150,000 | 15.26 | 2,289,750 |
| 2008-04-21 | Denny James M | Sale | 96,000 | 52.00 | 4,992,480 |
| 2008-04-21 | Denny James M | Option Exercise | 120,000 | 3.70 | 443,916 |
| 2008-04-10 | Young Kevin (EVP, Commercial Operations) | Sale | 30,000 | 51.53 | 1,545,975 |
| 2008-04-10 | Young Kevin (EVP, Commercial Operations) | Option Exercise | 30,000 | 16.84 | 505,275 |
| 2008-04-09 | Berg Paul | Sale | 13,450 | 52.20 | 702,056 |
| 2008-04-09 | Berg Paul | Option Exercise | 13,450 | 2.70 | 36,358 |
| 2008-04-08 | Martin John C (President and CEO) | Sale | 70,000 | 52.36 | 3,665,200 |
| 2008-04-08 | Martin John C (President and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2008-04-01 | Alton Gregg H (SVP, General Counsel) | Sale | 7,000 | 52.26 | 365,851 |
| 2008-04-01 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 7,000 | 8.94 | 62,597 |
| 2008-04-01 | Metza Kristen (SVP, Human Resources) | Sale | 7,500 | 52.35 | 392,597 |
| 2008-04-01 | Metza Kristen (SVP, Human Resources) | Option Exercise | 7,500 | 28.26 | 211,950 |
| 2008-03-25 | Alton Gregg H (SVP, General Counsel) | Sale | 51,500 | 50.12 | 2,581,327 |
| 2008-03-25 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 51,500 | 8.70 | 448,307 |
| 2008-03-12 | Berg Paul | Sale | 13,450 | 47.63 | 640,678 |
| 2008-03-12 | Berg Paul | Option Exercise | 13,450 | 2.70 | 36,358 |
| 2008-03-11 | Martin John C (President and CEO) | Sale | 70,000 | 46.31 | 3,241,560 |
| 2008-03-11 | Martin John C (President and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2008-03-06 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 7,000 | 8.94 | 62,597 |
| 2008-03-03 | Alton Gregg H (SVP, General Counsel) | Sale | 6,500 | 48.21 | 313,370 |
| 2008-03-03 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 6,500 | 8.47 | 55,038 |
| 2008-03-03 | Milligan John F (COO and CFO) | Sale | 60,000 | 48.01 | 2,880,409 |
| 2008-03-03 | Milligan John F (COO and CFO) | Option Exercise | 60,000 | 8.58 | 514,878 |
| 2008-02-29 | Alton Gregg H (SVP, General Counsel) | Sale | 500 | 47.00 | 23,500 |
| 2008-02-29 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 500 | 8.47 | 4,233 |
| 2008-02-26 | Moore Nicholas G | Sale | 48,000 | 43.84 | 2,100,160 |
| 2008-02-26 | Moore Nicholas G | Option Exercise | 48,000 | 15.86 | 761,040 |
| 2008-02-13 | Berg Paul | Sale | 13,450 | 45.58 | 613,024 |
| 2008-02-13 | Berg Paul | Option Exercise | 13,450 | 2.70 | 36,358 |
| 2008-02-08 | Bischofberger Norbert W (EVP, R&D and CSO) | Sale | 158,820 | 44.49 | 7,065,901 |
| 2008-02-08 | Bischofberger Norbert W (EVP, R&D and CSO) | Option Exercise | 170,000 | 11.05 | 1,878,500 |
| 2008-02-01 | Alton Gregg H (SVP, General Counsel) | Sale | 6,000 | 45.81 | 274,875 |
| 2008-02-01 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 6,000 | 8.47 | 50,804 |
| 2008-01-31 | Berg Paul | Sale | 10,000 | 45.04 | 450,375 |
| 2008-01-31 | Berg Paul | Option Exercise | 10,000 | 2.39 | 23,907 |
| 2008-01-29 | Denny James M | Sale | 96,000 | 43.02 | 4,129,574 |
| 2008-01-29 | Denny James M | Option Exercise | 120,000 | 4.44 | 532,974 |
| 2008-01-09 | Berg Paul | Sale | 13,000 | 46.99 | 610,930 |
| 2008-01-09 | Berg Paul | Option Exercise | 13,000 | 2.39 | 31,079 |
| 2008-01-08 | Martin John C (President and CEO) | Sale | 70,000 | 47.97 | 3,357,788 |
| 2008-01-08 | Martin John C (President and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2008-01-07 | Young Kevin (EVP, Commercial Operations) | Sale | 30,000 | 46.77 | 1,403,228 |
| 2008-01-07 | Young Kevin (EVP, Commercial Operations) | Option Exercise | 30,000 | 16.84 | 505,275 |
| 2008-01-04 | Alton Gregg H (SVP, General Counsel) | Sale | 40,500 | 47.00 | 1,903,500 |
| 2008-01-04 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 40,500 | 8.34 | 337,897 |
| 2008-01-02 | Alton Gregg H (SVP, General Counsel) | Sale | 56,000 | 45.91 | 2,575,533 |
| 2008-01-02 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 56,000 | 8.22 | 460,252 |
| 2007-12-21 | Milligan John F (COO) | Option Exercise | 6,500 | 3.70 | 24,070 |
| 2007-12-18 | Alton Gregg H (SVP, General Counsel) | Option Exercise | 11,984 | 8.34 | 99,984 |
| 2007-12-11 | Martin John C (President and CEO) | Sale | 70,000 | 46.52 | 3,256,527 |
| 2007-12-11 | Martin John C (President and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2007-12-04 | Martin John C (President and CEO) | Option Exercise | 42,408 | 3.68 | 155,885 |
| 2007-12-03 | Milligan John F (COO) | Sale | 60,000 | 46.00 | 2,760,103 |
| 2007-12-03 | Milligan John F (COO) | Option Exercise | 60,000 | 8.58 | 514,878 |
| 2007-11-14 | Berg Paul | Sale | 13,000 | 43.54 | 565,960 |
| 2007-11-14 | Berg Paul | Option Exercise | 13,000 | 2.39 | 31,079 |
| 2007-11-13 | Martin John C (President and CEO) | Sale | 70,000 | 42.21 | 2,954,661 |
| 2007-11-13 | Martin John C (President and CEO) | Option Exercise | 70,000 | 3.65 | 255,395 |
| 2007-11-07 | Denny James M | Sale | 60,000 | 45.27 | 2,727,835 |
| 2007-11-07 | Denny James M | Option Exercise | 80,000 | 5.18 | 414,688 |
| 2007-10-26 | Bischofberger Norbert W (EVP, Research) | Sale | 220,000 | 46.10 | 10,142,785 |
| 2007-10-26 | Bischofberger Norbert W (EVP, Research) | Option Exercise | 200,000 | 8.94 | 1,788,500 |
| 2007-10-25 | Berg Paul | Sale | 6,500 | 44.75 | 290,875 |
| 2007-10-25 | Berg Paul | Option Exercise | 10,000 | 2.39 | 23,907 |
| 2007-10-23 | Davignon Etienne | Sale | 35,000 | 42.61 | 1,491,350 |
| 2007-10-09 | Young Kevin (EVP, Commercial Operations) | Sale | 30,000 | 41.57 | 1,246,994 |
| 2007-10-09 | Young Kevin (EVP, Commercial Operations) | Option Exercise | 30,000 | 16.84 | 505,275 |
| 2007-10-09 | Martin John C (President and CEO) | Purchase | 10,000 | 41.84 | 418,400 |
| 2007-10-09 | Martin John C (President and CEO) | Sale | 60,000 | 41.75 | 2,505,272 |
| 2007-10-09 | Martin John C (President and CEO) | Option Exercise | 70,000 | 2.54 | 177,737 |
| 2007-09-12 | Berg Paul | Sale | 13,000 | 37.92 | 492,931 |
| 2007-09-12 | Berg Paul | Option Exercise | 13,000 | 2.39 | 31,079 |
| 2007-09-11 | Davignon Etienne | Option Exercise | 80,000 | 2.39 | 191,256 |
| 2007-09-11 | Martin John C (President and CEO) | Sale | 70,000 | 37.94 | 2,655,646 |
| 2007-09-11 | Martin John C (President and CEO) | Option Exercise | 70,000 | 1.43 | 100,079 |
| 2007-09-07 | Moore Gordon Earle | Option Exercise | 144,000 | 2.39 | 344,260 |
| 2007-09-04 | Milligan John F (COO and CFO) | Sale | 60,000 | 36.70 | 2,201,742 |
| 2007-09-04 | Milligan John F (COO and CFO) | Option Exercise | 60,000 | 6.74 | 404,589 |
Go to page: 1
2
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Gilead Sciences Inc (symbol GILD,
CIK number 882095) see
the Securities and Exchange Commission (SEC) website.
|
|
